Edition:
United States

Karyopharm Therapeutics Inc (KPTI.OQ)

KPTI.OQ on NASDAQ Stock Exchange Global Select Market

18.20USD
4:00pm EDT
Change (% chg)

$0.26 (+1.45%)
Prev Close
$17.94
Open
$17.97
Day's High
$18.49
Day's Low
$17.57
Volume
135,625
Avg. Vol
255,751
52-wk High
$20.38
52-wk Low
$8.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.86 December 16 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 5
(2) OUTPERFORM 4 4 5 5
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.90 1.90 1.91 1.73

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 10 0.46 2.30 0.00 0.00
Quarter Ending Dec-18 10 0.44 2.46 0.00 0.00
Year Ending Dec-18 10 28.82 34.65 10.00 15.99
Year Ending Dec-19 10 33.44 90.60 4.60 80.35
Earnings (per share)
Quarter Ending Sep-18 10 -0.86 -0.71 -0.96 -0.63
Quarter Ending Dec-18 10 -0.89 -0.72 -1.00 -0.65
Year Ending Dec-18 10 -3.22 -2.94 -3.66 -2.30
Year Ending Dec-19 10 -2.53 3.18 -3.98 -1.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 3.09 19.89 16.81 544.60
Quarter Ending Mar-18 5.84 10.00 4.16 71.32
Quarter Ending Dec-17 0.03 1.53 1.50 4,359.30
Quarter Ending Sep-17 0.03 0.00 0.03 100.00
Quarter Ending Jun-17 0.12 0.00 0.12 97.46

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.46 0.46 0.73 0.67 0.00
Quarter Ending Dec-18 0.44 0.44 0.70 0.64 0.00
Year Ending Dec-18 28.82 26.92 14.52 14.11 15.99
Year Ending Dec-19 33.44 32.94 30.17 30.94 80.35

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 1
Quarter Ending Dec-18 0 0 0 1
Year Ending Dec-18 1 0 9 0
Year Ending Dec-19 1 0 3 2
Earnings